These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 34844772)

  • 1. Targeting neurological abnormalities in lysosomal storage diseases.
    van Gool R; Tucker-Bartley A; Yang E; Todd N; Guenther F; Goodlett B; Al-Hertani W; Bodamer OA; Upadhyay J
    Trends Pharmacol Sci; 2022 Jun; 43(6):495-509. PubMed ID: 34844772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in therapies for neurological lysosomal storage disorders.
    Ellison S; Parker H; Bigger B
    J Inherit Metab Dis; 2023 Sep; 46(5):874-905. PubMed ID: 37078180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the central nervous system in lysosomal storage diseases: Strategies to deliver therapeutics across the blood-brain barrier.
    Critchley BJ; Gaspar HB; Benedetti S
    Mol Ther; 2023 Mar; 31(3):657-675. PubMed ID: 36457248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzyme enhancement therapeutics for lysosomal storage diseases: Current status and perspective.
    Thomas R; Kermode AR
    Mol Genet Metab; 2019 Feb; 126(2):83-97. PubMed ID: 30528228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysregulation of autophagy as a common mechanism in lysosomal storage diseases.
    Seranova E; Connolly KJ; Zatyka M; Rosenstock TR; Barrett T; Tuxworth RI; Sarkar S
    Essays Biochem; 2017 Dec; 61(6):733-749. PubMed ID: 29233882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delineating the Neuropathology of Lysosomal Storage Diseases Using Patient-Derived Induced Pluripotent Stem Cells.
    Sabitha KR; Chandran D; Shetty AK; Upadhya D
    Stem Cells Dev; 2022 May; 31(9-10):221-238. PubMed ID: 35316126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autophagy and Lysosome Storage Disorders.
    Ren H; Wang G
    Adv Exp Med Biol; 2020; 1207():87-102. PubMed ID: 32671740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clarifying lysosomal storage diseases.
    Schultz ML; Tecedor L; Chang M; Davidson BL
    Trends Neurosci; 2011 Aug; 34(8):401-10. PubMed ID: 21723623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysosomal storage disorders - challenges, concepts and avenues for therapy: beyond rare diseases.
    Marques ARA; Saftig P
    J Cell Sci; 2019 Jan; 132(2):. PubMed ID: 30651381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From Lysosomal Storage Disorders to Parkinson's Disease - Challenges and Opportunities.
    Mächtel R; Boros FA; Dobert JP; Arnold P; Zunke F
    J Mol Biol; 2023 Jun; 435(12):167932. PubMed ID: 36572237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug delivery for neuronopathic lysosomal storage diseases: evolving roles of the blood brain barrier and cerebrospinal fluid.
    Sato Y; Minami K; Hirato T; Tanizawa K; Sonoda H; Schmidt M
    Metab Brain Dis; 2022 Aug; 37(6):1745-1756. PubMed ID: 35088290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Astrocytes and lysosomal storage diseases.
    Rama Rao KV; Kielian T
    Neuroscience; 2016 May; 323():195-206. PubMed ID: 26037807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A block of autophagy in lysosomal storage disorders.
    Settembre C; Fraldi A; Jahreiss L; Spampanato C; Venturi C; Medina D; de Pablo R; Tacchetti C; Rubinsztein DC; Ballabio A
    Hum Mol Genet; 2008 Jan; 17(1):119-29. PubMed ID: 17913701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autophagy in lysosomal storage disorders.
    Lieberman AP; Puertollano R; Raben N; Slaugenhaupt S; Walkley SU; Ballabio A
    Autophagy; 2012 May; 8(5):719-30. PubMed ID: 22647656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysosomal Storage Disease-Associated Neuropathy: Targeting Stable Nucleic Acid Lipid Particle (SNALP)-Formulated siRNAs to the Brain as a Therapeutic Approach.
    Coutinho MF; Santos JI; S Mendonça L; Matos L; Prata MJ; S Jurado A; Pedroso de Lima MC; Alves S
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32785133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of
    Sellin J; Schulze H; Paradis M; Gosejacob D; Papan C; Shevchenko A; Psathaki OE; Paululat A; Thielisch M; Sandhoff K; Hoch M
    Dis Model Mech; 2017 Jun; 10(6):737-750. PubMed ID: 28389479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolving therapies in neuronopathic LSDs: opportunities and challenges.
    Rajan DS; Escolar ML
    Metab Brain Dis; 2022 Oct; 37(7):2245-2256. PubMed ID: 35442005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial Dysfunction and Neurodegeneration in Lysosomal Storage Disorders.
    Plotegher N; Duchen MR
    Trends Mol Med; 2017 Feb; 23(2):116-134. PubMed ID: 28111024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysosomal Storage Diseases-Regulating Neurodegeneration.
    Onyenwoke RU; Brenman JE
    J Exp Neurosci; 2015; 9(Suppl 2):81-91. PubMed ID: 27081317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurodegenerative Lysosomal Storage Disorders: TPC2 Comes to the Rescue!
    Prat Castro S; Kudrina V; Jaślan D; Böck J; Scotto Rosato A; Grimm C
    Cells; 2022 Sep; 11(18):. PubMed ID: 36139381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.